Salvatore De Vita

InstitutionUniversity of Udine
AddressUdine
Italy
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 8 Covid-19 publications, with a maximum of 3 publications in May 2020
    All Publications
    Bar chart showing 149 publications over 20 distinct years, with a maximum of 17 publications in 2019
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Quartuccio L, Treppo E, Binutti M, Del Frate G, De Vita S. Timing of rituximab and immunoglobulin level influence the risk of death for COVID-19 in ANCA-associated vasculitis. Rheumatology (Oxford). 2021 07 01; 60(7):3476-3477. PMID: 33609106.
      Citations: 3     Fields:    Translation:Humans
    2. Quartuccio L, De Marchi G, Azzolina D, Maresio E, Colatutto D, Binutti M, Monte M, Gallipoli S, Zobec F, Lanera C, Lorenzoni G, Palese A, Silano M, De Vita S, Gregori D. Psychological Effects of Lockdown Measures for the COVID-19 Outbreak in Patients with Systemic Lupus Erythematosus. J Multidiscip Healthc. 2021; 14:1475-1488. PMID: 34168460.
      Citations: 1     
    3. Quartuccio L, Valent F, Pasut E, Tascini C, De Vita S. Rev Rhum Ed Fr. 2021 Oct; 88(5):377-381. PMID: 34007141.
      Citations:    Fields:    
    4. Quartuccio L, Benucci M, De Vita S. Answer to Vieira et al. "Cytokine profile as a prognostic tool in coronavirus disease 2019". Joint Bone Spine 2020. Doi:10.1016/j.jbspin.2020.09.006. Joint Bone Spine. 2021 01; 88(1):105076. PMID: 32950703.
      Citations:    Fields:    Translation:Humans
    5. Quartuccio L, Sonaglia A, Pecori D, Peghin M, Fabris M, Tascini C, De Vita S. Higher levels of IL-6 early after tocilizumab distinguish survivors from nonsurvivors in COVID-19 pneumonia: A possible indication for deeper targeting of IL-6. J Med Virol. 2020 11; 92(11):2852-2856. PMID: 32515499.
      Citations: 19     Fields:    Translation:Humans
    6. Quartuccio L, Valent F, Pasut E, Tascini C, De Vita S. Prevalence of COVID-19 among patients with chronic inflammatory rheumatic diseases treated with biologic agents or small molecules: A population-based study in the first two months of COVID-19 outbreak in Italy. Joint Bone Spine. 2020 10; 87(5):439-443. PMID: 32445935.
      Citations: 28     Fields:    Translation:HumansPHPublic Health
    7. Quartuccio L, Sonaglia A, McGonagle D, Fabris M, Peghin M, Pecori D, De Monte A, Bove T, Curcio F, Bassi F, De Vita S, Tascini C. Profiling COVID-19 pneumonia progressing into the cytokine storm syndrome: Results from a single Italian Centre study on tocilizumab versus standard of care. J Clin Virol. 2020 08; 129:104444. PMID: 32570043.
      Citations: 65     Fields:    Translation:HumansPHPublic Health
    8. Quartuccio L, Semerano L, Benucci M, Boissier MC, De Vita S. Urgent avenues in the treatment of COVID-19: Targeting downstream inflammation to prevent catastrophic syndrome. Joint Bone Spine. 2020 05; 87(3):191-193. PMID: 32321634.
      Citations: 24     Fields:    Translation:HumansCellsPHPublic Health